03-06-2026 11:45 via drugs.com

GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30%

WEDNESDAY, June 3, 2026— Taking Ozempic or Zepbound might lower a woman’s risk of breast cancer, a new study says.Women with excess weight taking GLP-1 drugs were about 30% less likely to develop breast cancer than those not taking such...
Read more »

Pharmaceutical news



High Prevalence of Clinical Obesity Seen Even With Normal BMI
FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection
ASCO: Lower Incidence of Breast Cancer Seen With GLP-1 Receptor Agonist Exposure
ASCO: First-Line Sunvozertinib Beats Chemo for Advanced NSCLC
Patients From Most Rural Counties Have Worse Epilepsy Outcomes
2024 Saw Parkinson Disease Death Rate of 72 Per 100,000 Adults Aged 65 and Older
Resistance Training Tied to Lower Risk for Death Across Causes
Gut Microbial, Metabolomic Alterations Persist After Adenoma Resection
Cumulative Attrition for Surgeons 9.7 Percent Over Eight Years
Poll Finds Broad Support For Stricter Regulations On Ultra-Processed Foods
Microbially Derived Metabolites in Urine May Help Identify Autism in Children
Nearly 1 in 5 Young People Turn to AI Chatbots for Mental Health Advice
Home-Delivered Medical Meals Reduce ER Visits, Save Money
Night Owls Are More Prone To Anxiety, Loneliness
Desktop versie